Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
⚡ Epilepsy = a chronic brain disorder causing a persistent propensity to unprovoked seizures. Prevalence ~0.5–1%; bimodal peaks (👶 childhood, 🧓 older adults). 🎯 Core aims: correct diagnosis → precise classification → personalised therapy with the fewest adverse effects, while optimising learning, work, driving, pregnancy, and quality of life.
Seizure/Epilepsy | Adults (first-line) | Children (first-line) | Avoid/Warn |
---|---|---|---|
Focal ± focal→bilateral | Levetiracetam, Lamotrigine, Carbamazepine, Lacosamide | Levetiracetam, Lamotrigine, Carbamazepine | Carbamazepine may worsen generalised epilepsies |
Generalised tonic–clonic | Levetiracetam, Lamotrigine, Valproate* | Levetiracetam; Valproate (boys) | *Valproate: teratogenic—avoid in women of childbearing potential unless PPP met |
Absence (CAE) | Ethosuximide, Valproate, Lamotrigine | Ethosuximide (best), Valproate | Avoid carbamazepine/oxcarb (can exacerbate) |
Myoclonic (e.g., JME) | Valproate*, Levetiracetam | Valproate (boys), Levetiracetam | Lamotrigine may worsen myoclonus |
Atonic/Lennox–Gastaut | Valproate*, Lamotrigine, Clobazam, Rufinamide, Topiramate | Valproate, Lamotrigine; Ketogenic diet | Consider VNS; polytherapy often needed |
Drug | Key AEs | Labs/Notes | Interactions |
---|---|---|---|
Levetiracetam | Irritability, mood change | Usually no labs; consider mood screen | Minimal CYP interactions |
Lamotrigine | Rash (SJS/TEN), dizziness | Titrate slowly; levels drop in pregnancy | ↑ by inducers; ↑ toxicity with valproate |
Carbamazepine | Diplopia, hyponatraemia, leukopenia | U&E, FBC, LFT; troughs if needed | Enzyme inducer ↓ OCPs; many CYP interactions |
Valproate | Weight gain, tremor, thrombocytopenia | LFT, platelets; counsel teratogenicity | Inhibits UGT (↑ lamotrigine) |
Topiramate | Cognitive fog, nephrolithiasis | Bicarbonate if symptomatic (acidosis) | ↓ OCP efficacy (dose-dependent) |
Lacosamide | PR prolongation, dizziness | ECG if heart disease | Few interactions; caution with other PR-prolongers |
Definition: ≥5 min of generalised tonic–clonic activity or recurrent seizures without recovery. Priorities: ABCDE, oxygenation, stop the seizure, treat the cause, prevent complications.